Abstract 12690: Outcomes of Tricuspid Valve Surgery in Patients With Septic Pulmonary Embolism From Drug-Associated Tricuspid Valve Endocarditis

• Published in: Circulation (New York, N.Y.) N.Y.), 2021-11, Vol.144 (Suppl_1), p.A12690-A12690
• Main Authors: Siddiqui, Emaad, Alviar, Carlos, Ramachandran, Abhinay, Flattery, Erin, Keller, Norma M, Bangalore, Sripal
• Format: Article
• Language: English
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/circ.144.suppl_1.12690

IntroductionSeptic pulmonary emboli (PE) are a common sequela of drug-use associated infective endocarditis (DU-IE) of the tricuspid valve and is considered an indication for surgery. MethodsThe Healthcare Cost and Utilization Project’s National Inpatient Sample was queried from 2008-2017 for adult patients hospitalized for septic PE with the diagnosis of DU-IE of the tricuspid valve. In-hospital outcomes of patients who underwent tricuspid valve operation (TVO) were compared with patients who did not. The primary outcome was perioperative major adverse cardiovascular events (MACE) defined as a composite of death, myocardial infarction (MI), stroke, cardiogenic shock, and cardiac arrest. ResultsA total of 6,758 cases of DU-IE with septic PE were identified (mean age 32.2), of which 2,262 (33.6%) had a TVO during hospital admission. Patients who underwent a TVO had longer length of stay (32.3 vs 17.7, p